Browse studies

Find your next paid study

27,370 recruiting studies available now

Modifying Adiposity Through Behavioral Strategies to Improve COVID-19 Rehabilitation

The research in this VA Merit will examine the effects of obesity and Post-COVID Conditions (PCC) on physical functioning, health-related quality of life, and …

Post-COVID ConditionsObesity

Estimated

~$10 – $675

Actual pay is set by the research site.

VA Office of Research and DevelopmentNCT05880108

Phase 4

CVD 38000: Immunity, Microbiome, Epigenetics, and a Systems Biology Approach to the Study of Responses to Vaccination With Typhoid and/or Cholera

This is an open-label, non-randomized study. The purpose of this study is to better understand how vaccines against typhoid fever and cholera affect the normal…

Typhoid and/or Cholera Vaccination

Estimated

~$25 – $1,000

Actual pay is set by the research site.

University of Maryland, BaltimoreNCT03705585

Phase 1

An Adaptive Two-Part, Phase 1/2, Multi-Center, Double-Blinded, Randomized, Controlled Study of the Safety and Efficacy of Topically Applied PEP-TISSEEL in Participants With Chronic Radiation Ulcer

The goal of this clinical trial is to learn if drug Purified Exosome Product (PEP™) and Fibrin Sealant (TISSEEL® VH SD Kit) (PEP-TISSEEL) works to treat chroni…

Chronic Radiation Ulcer

Estimated

~$150 – $4,200

Actual pay is set by the research site.

Rion Inc.NCT06793748

Phase 1

A Phase 1/2 Clinical Trial of the Novel Topoisomerase I Inhibitor PEEL-224 as a Single Agent and in Combination With Vincristine and Temozolomide in Children With Refractory, Progressive or Relapsed Solid Tumors

The phase 1 primary objective is to determine the pediatric recommended phase 2 dose (RP2D) of PEEL-224 as a single agent (phase 1A) and in combination with vi…

Refractory Solid TumorsRelapsed Solid TumorsRelapsed Neuroblastoma+3 more

Estimated

~$150 – $4,500

Actual pay is set by the research site.

Theodore LaetschNCT06721689

Phase 2

Phase II Biomarker Study of BND-22 in Combination With Cemiplimab in Solid Tumors

To study possible biomarkers that may be related to how SAR444881 works (either alone or when combined with cemiplimab) in participants with solid tumors.

Solid Tumors

Estimated

~$75 – $2,000

Actual pay is set by the research site.

M.D. Anderson Cancer CenterNCT06651593

Data, Tissue, Blood, and Urine Repository for Amyloid Diseases

RATIONALE: Collecting and storing samples of blood, urine, tissue and data from patients with amyloid diseases to test in the laboratory may help the study of …

Multiple Myeloma

Estimated

~$10 – $750

Actual pay is set by the research site.

Boston Medical CenterNCT00898235

Phase 2

Alcohol Use Disorder and Cannabis: Testing Novel Harm Reduction Strategies

This is a double-blind, placebo-controlled, parallel group study designed to assess the efficacy of full spectrum CBD and broad spectrum CBD, compared to a pla…

Alcohol Use Disorder

Estimated

~$75 – $2,000

Actual pay is set by the research site.

University of Colorado, DenverNCT05613608

Observational

The Development and Validation of Neural Targets in Opioid Use Disorder

In this research study the investigators will work with 80-participants with opioid use disorder who are starting treatment with the medication buprenorphine a…

Opioid Use Disorder

Estimated

~$10 – $750

Actual pay is set by the research site.

Duke UniversityNCT06585709

Phase 2

MC230808 Reduced Dose Hypofractionated Radiotherapy (3Gy x 3 Fractions) for Indolent Non-Hodgkin Lymphoma (POSEIDON): A Multisite Phase 2 Randomized Trial

This phase II trial compares the safety, side effects and effectiveness of reduced dose radiation therapy to standard of care dose radiation in treating patien…

Indolent B-Cell Non-Hodgkin LymphomaRecurrent Indolent B-Cell Non-Hodgkin LymphomaRefractory Indolent B-Cell Non-Hodgkin Lymphoma+2 more

Estimated

~$75 – $2,000

Actual pay is set by the research site.

Mayo ClinicNCT06386315

Observational

Deep Brain Stimulation Neural Recordings of Varied Stimulation During Sleep in Parkinson's Disease - The DREAMS-PD Study

This study employs an exploratory, prospective, single center, naturalistic clinical trial design with a randomized crossover intervention.

Parkinson Disease

Estimated

~$10 – $750

Actual pay is set by the research site.

The Cleveland ClinicNCT07110376

Phase 1

Phase Ib Open-label Study of Adjuvant CUE-102, a WT-1-pHLA-IL2-Fc Fusion Protein in Glioblastoma (GBM) Patients at First Recurrence

The goal of this study is to evaluate the safety of the experimental drug, CUE-102, and establish the recommended dose of CUE-102 for participants with Recurre…

Recurrent GlioblastomaGlioblastomaGlioma, Malignant

Estimated

~$150 – $4,500

Actual pay is set by the research site.

David Reardon, MDNCT06917885

Phase 4

OCTAGON: A Phase 4, Single Arm Study to Investigate Oral Corticosteroid Tapering in Adult Patients With Generalized Myasthenia Gravis Treated With Ravulizumab

This is a prospective, multicenter single arm study designed to evaluate the effectiveness and safety of a predefined oral corticosteroids (OCS) tapering sched…

Generalized Myasthenia GravisgMG

Estimated

~$25 – $1,400

Actual pay is set by the research site.

Alexion Pharmaceuticals, Inc.NCT07221838